Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Cero Therapeutics Holdings, Inc.”

4 pharma patents match "Cero Therapeutics Holdings, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Cero Therapeutics Holdings, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Cero Therapeutics Holdings, Inc.” · 30,257 patents in full index Clear search

  1. US 12303551

    Cellular immunotherapy compositions and uses thereof

    Cero Therapeutics Holdings, Inc. · Granted May 20, 2025 · Expires May 15, 2045

    granted

  2. US 12291557

    Chimeric TIM4 receptors and uses thereof

    Cero Therapeutics Holdings, Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted

  3. US 11708423

    Chimeric engulfment receptor molecules and methods of use

    Cero Therapeutics Holdings, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  4. US 11655282

    Chimeric engulfment receptor molecules

    Cero Therapeutics Holdings, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.